Author:
Bazzi Ali M.,Al-Tawfiq Jaffar A.,Rabaan Ali A.,Neal Dianne,Ferraro Aimee,Fawarah Mahmoud M.
Abstract
Background:Methicillin-resistantStaphylococcus aureus(MRSA) infection is associated with increased morbidity, mortality, and financial burdens. Phenotyping methods are used to classify MRSA as either health care MRSA (HA-MRSA) or community-associated MRSA (CA-MRSA). Recent studies suggested the phenotyping methods are not always reliable, based on a lack of concordance with genotyping results.Objective:In this study, concordance of classification methods based on clinical characteristics or antibiotic susceptibility compared to the gold standard genotyping was assessed in the classification of MRSA.Methods:We compared the genotypes and phenotypes of MRSA in 133 samples taken from patients in Saudi Arabia. Statistical analyses included concordance, specificity and sensitivity, and logistic regression modeling.Results:There was fair a definite agreement between the health care risk and infection type methods (p< .001), but no statistically significant agreement between the susceptibility pattern and health care risk methods (p= 243), and between susceptibility pattern and infection type methods (p= .919). Reduced multiple regression modelling suggested the potential of a phenotyping-based method of antibiotic susceptibility pattern (OR = 15.47,p< .001) in conjunction with hospital admission profile(OR = 2.87,p= .008) to accurately identify MRSA as HA-MRSA and CA-MRSA.Conclusion:The use of a standardized phenotyping technique, using susceptibility pattern and hospital admission profiles to classify MRSA infections as either HA-MRSA or CA-MRSA, would facilitate diagnosis, infection control efforts, prevention, and assignment of appropriate therapies. The ability to use phenotyping in the classification of these strains would improve efforts to contend with this adept and evolving bacterial organism.
Publisher
Bentham Science Publishers Ltd.
Subject
General Immunology and Microbiology
Reference49 articles.
1. David MZ, Glikman D, Crawford SE, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197 (9) : 1235-43.
2. Centers for Disease Control and Prevention(CDC).. Antibiotic resistance threat in the United States 2013. Available at: https://www.cdc.gov/drugresistance/threat-report-2013/
3. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13 (10) : 582-6.
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare infection control practices advisory committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35 (10) (Suppl. 2) : S165-93.
5. Inweregbu K, Dave J. Pittard. A. Nosocomial infections. Contin Educ Anaesth Crit Care Pain 2005; 5 (1) : 14-7.